Keyphrases
Chronic Obstructive Pulmonary Disease
100%
Kynurenine
100%
Skeletal muscle
100%
Kynurenine Metabolism
100%
Chronic Obstructive Pulmonary Disease Patient
50%
Peroxisome Proliferator-activated Receptor
50%
Coactivator
50%
Mental Health
33%
Plasma Parameters
33%
Muscle Tissue
33%
Kynurenine Aminotransferase
33%
Airway Obstruction
16%
Cognitive Impairment
16%
Healthy Controls
16%
Gene Expression
16%
Physical Health
16%
Signaling Pathway
16%
Gene Expression Level
16%
Muscle Biopsy
16%
Exercise Training
16%
Systemic Manifestations
16%
Oxidative Phenotype
16%
Quadriceps muscle
16%
Protein Expression Level
16%
Peroxisome Proliferator-activated Receptor-γ coactivator-1α (PGC-1α)
16%
Background Loss
16%
Major Constituents
16%
Nutritional Modulation
16%
Peripheral muscle
16%
KAT1
16%
INIS
diseases
100%
patients
100%
muscles
100%
metabolism
100%
kynurenine
100%
levels
44%
plasma
33%
tissues
22%
genes
22%
aminotransferases
22%
data
11%
biopsy
11%
control
11%
receptors
11%
blood
11%
modulation
11%
phenotype
11%
losses
11%
proteins
11%
clearance
11%
hypothesis
11%
exercise
11%
oxidation
11%
air flow
11%
Immunology and Microbiology
Skeletal Muscle
100%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
100%
Blood Level
50%
Muscle Tissue
50%
Mental Health
50%
Blood Plasma
25%
Signal Transduction
25%
Gene Expression
25%
Airflow
25%
Exercise
25%
Gene Expression Level
25%
Protein Expression Level
25%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
100%
Skeletal Muscle
100%
Kynurenine
100%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
44%
Blood Level
22%
Transaminase
22%
Mental Health
22%
Gene Expression
11%
Exercise
11%
Signal Transduction
11%
Airflow
11%
Gene Expression Level
11%
Protein Expression Level
11%
Blood Plasma
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Kynurenine
100%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
50%
Kynurenine Aminotransferase
25%
Cognitive Defect
12%
Airway Obstruction
12%